Pyrrolidine dithiocarbamate inhibits induction of immunoproteasome and decreases survival in a rat model of amyotrophic lateral sclerosis

Molecular Pharmacology

Volumn 71, Issue 1, 2007, Pages 30-37

  Ahtoniemi, Toni ^a   Goldsteins, Gundars ^a   Keksa Goldsteine, Velta ^a   Malm, Tarja ^a   Kanninen, Katja ^a   Salminen, Antero ^a   Koistinaho, Jari ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; PYRROLIDINE DITHIOCARBAMATE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DISEASE COURSE; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD; SURVIVAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIOXIDANTS; DEATH; DISEASE MODELS, ANIMAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; MOTOR NEURON DISEASE; NEUROGLIA; PYRROLIDINES; RATS; SUPEROXIDE DISMUTASE; SURVIVAL RATE; THIOCARBAMATES;

EID: 33845872810     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.106.028415     Document Type: Article

References (40)

1. Alexianu ME, Kozovska M, and Appel SH (2001) Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology 57:1282-1289.
2. Bruijn LI, Miller TM, and Cleveland DW (2004) Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 27:723-749.
3. Calviello G, Filippi GM, Toesca A, Palozza P, Maggiano N, Nicuolo FD, Serini S, Azzena GB, and Galeotti T (2005) Repeated exposure to pyrrolidine-dithiocarbamate induces peripheral nerve alterations in rats. Toxicol Lett 158:61-71.
4. Cheng G, Whitehead SN, Hachinski V, and Cechetto DF (2006) Effects of pyrrolidine dithiocarbamate on beta-amyloid (25-35)-induced inflammatory responses and memory deficits in the rat. Neurobiol Dis 23:140-151.
5. Cheroni C, Peviani M, Cascio P, Debiasi S, Monti C, and Bendotti C (2005) Accumulation of human SOD1 and ubiquitinated deposits in the spinal cord of SOD1G93A mice during motor neuron disease progression correlates with a decrease of proteasome. Neurobiol Dis 18:509-522.
6. Cuzzocrea S, Chatterjee PK, Mazzon E, Dugo L, Serraino I, Britti D, Mazzullo G, Caputi AP, and Thiemermann C (2002) Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammation. Br J Pharmacol 135:496-510.
7. DeMartino GN and Slaughter CA (1999) The proteasome, a novel protease regulated by multiple mechanisms. J Biol Chem 274:22123-22126.
8. Drachman DB, Frank K, Dykes-Hoberg M, Teismann P, Almer G, Przedborski S, and Rothstein JD (2002) Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS. Ann Neurol 52:771-778.
9. Elliott JL (2001) Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis. Brain Res Mol Brain Res 95:172-178.
10. Gong YH, Parsadanian AS, Andreeva A, Snider WD, and Elliott JL (2000) Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration. J Neurosci 20:660-665.
11. Gurney ME, Cutting FB, Zhai P, Doble A, Taylor CP, Andrus PK, and Hall ED (1996) Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neurol 39:147-157.
12. Hayakawa M, Miyashita H, Sakamoto I, Kitagawa M, Tanaka H, Yasuda H, Karin M, and Kikugawa K (2003) Evidence that reactive oxygen species do not mediate NF-kappaB activation. EMBO (Eur Mol Biol Organ) J 22:3356-3366.
13. Helenius M, Hanninen M, Lehtinen SK, and Salminen A (1996) Changes associated with aging and replicative senescence in the regulation of transcription factor nuclear factor-kappa B. Biochem J 318 (Pt 2):603-608.
14. Howland DS, Liu J, She Y, Goad B, Maragakis NJ, Kim B, Erickson J, Kulik J, DeVito L, Psaltis G, et al. (2002) Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc Natl Acad Sci USA 99:1604-1609.
15. Kiaei M, Petri S, Kipiani K, Gardian G, Choi DK, Chen J, Calingasan NY, Schafer P, Muller GW, Stewart C, et al. (2006) Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis. J Neurosci 26:2467-2473.
16. Kim I, Kim CH, Kim JH, Lee J, Choi JJ, Chen ZA, Lee MG, Chung KC, Hsu CY, and Ahn YS (2004) Pyrrolidine dithiocarbamate and zinc inhibit proteasome-dependent proteolysis. Exp Cell Res 298:229-238.
17. Koh SH, Lee YB, Kim KS, Kim HJ, Kim M, Lee YJ, Kim J, Lee KW, and Kim SH (2005) Role of GSK-3beta activity in motor neuronal cell death induced by G93A or A4V mutant hSOD1 gene. Eur J Neurosci 22:301-309.
18. Kriz J, Nguyen MD, and Julien JP (2002) Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 10:268-278.
19. La Rosa G, Cardali S, Genovese T, Conti A, Di Paola R, La Torre D, Cacciola F, and Cuzzocrea S (2004) Inhibition of the nuclear factor-kappaB activation with pyrrolidine dithiocarbamate attenuating inflammation and oxidative stress after experimental spinal cord trauma in rats. J Neurosurg Spine 1:311-321.
20. Lino MM, Schneider C, and Caroni P (2002) Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. J Neurosci 22:4825-4832.
21. Liu SF, Ye X, and Malik AB (1999) Inhibition of NF-kappaB activation by pyrrolidine dithiocarbamate prevents In vivo expression of proinflammatory genes. Circulation 100:1330-1337.
22. Matsui N, Kasajima K, Hada M, Nagata T, Senga N, Yasui Y, Fukuishi N, and Akagi M (2005) Inhibition of NF-kappaB activation during ischemia reduces hepatic ischemia/reperfusion injury in rats. J Toxicol Sci 30:103-110.
23. Mattson MP and Camandola S (2001) NF-kappaB in neuronal plasticity and neurodegenerative disorders. J Clin Investig 107:247-254.
24. Messina S, Bitto A, Aguennouz M, Minutoli L, Monici MC, Altavilla D, Squadrito F, and Vita G (2006) Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice. Exp Neurol 198:234-241.
25. Migheli A, Piva R, Atzori C, Troost D, and Schiffer D (1997) c-Jun, JNK/SAPK kinases and transcription factor NF-kappa B are selectively activated in astrocytes, but not motor neurons, in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 56:1314-1322.
26. Mulder DW, Kurland LT, Offord KP, and Beard CM (1986) Familial adult motor neuron disease: amyotrophic lateral sclerosis. Neurology 36:511-517.
27. Nguyen MD, Julien JP, and Rivest S (2001) Induction of proinflammatory molecules in mice with amyotrophic lateral sclerosis: no requirement for proapoptotic interleukin-1beta in neurodegeneration. Ann Neurol 50:630-639.
28. Nurmi A, Goldsteins G, Narvainen J, Pihlaja R, Ahtoniemi T, Grohn O, and Koistinaho J (2006) Antioxidant pyrrolidine dithiocarbamate activates Akt-GSK signaling and is neuroprotective in neonatal hypoxia-ischemia. Free Radic Biol Med 40:1776-1784.
29. Nurmi A, Lindsberg PJ, Koistinaho M, Zhang W, Juettler E, Karjalainen-Lindsberg ML, Weih F, Frank N, Schwaninger M, and Koistinaho J (2004a) Nuclear factorkappaB contributes to infarction after permanent focal ischemia. Stroke 35:987-991.
30. Nurmi A, Vartiainen N, Pihlaja R, Goldsteins G, Yrjanheikki J, and Koistinaho J (2004b) Pyrrolidine dithiocarbamate inhibits translocation of nuclear factor kappa-B in neurons and protects against brain ischaemia with a wide therapeutic time window. J Neurochem 91:755-765.
31. Pramatarova A, Laganiere J, Roussel J, Brisebois K, and Rouleau GA (2001) Neuronspecific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J Neurosci 21:3369-3374.
32. Puttaparthi K and Elliott JL (2005) Non-neuronal induction of immunoproteasome subunits in an ALS model: possible mediation by cytokines. Exp Neurol 196:441-451.
33. Reisinger EC, Kern P, Ernst M, Bock P, Flad HD, and Dietrich M (1990) Inhibition of HIV progression by dithiocarb. German DTC Study Group. Lancet 335:679-682.
34. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature (Lond) 362:59-62.
35. Rothstein JD, Patel S, Regan MR, Haenggeli C, Huang YH, Bergles DE, Jin L, Dykes Hoberg M, Vidensky S, Chung DS, et al. (2005) Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature (Lond) 433:73-77.
36. Schreck R, Meier B, Mannel DN, Droge W, and Baeuerle PA (1992) Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med 175:1181-1194.
37. Tortarolo M, Veglianese P, Calvaresi N, Botturi A, Rossi C, Giorgini A, Migheli A, and Bendotti C (2003) Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression. Mol Cell Neurosci 23:180-192.
38. Van Den Bosch L, Tilkin P, Lemmens G, and Robberecht W (2002) Minocycline delays disease onset and mortality in a transgenic model of ALS. Neuroreport 13:1067-1070.
39. Wu AS, Kiaei M, Aguirre N, Crow JP, Calingasan NY, Browne SE, and Beal MF (2003) Iron porphyrin treatment extends survival in a transgenic animal model of amyotrophic lateral sclerosis. J Neurochem 85:142-150.
40. Zhu S, Stavrovskaya IG, Drozda M, Kim BY, Ona V, Li M, Sarang S, Liu AS, Hartley DM, Wu du C, et al. (2002) Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature (Lond) 417:74-78.